Hippo Holdings heads into its July 30 earnings date with options positioning near its most bullish extreme of the past year, even as insiders have been quietly trimming throughout the quarter.
The options signal is the standout this week. Call demand has overwhelmed puts — the put/call ratio dropped to 0.02, nearly its 52-week low of 0.02 and well below the 20-day average of 0.27. The z-score of -0.84 is less dramatic than the raw ratio, but the direction is clear: this is the least hedged the options market has looked at any point in the past twelve months. The shift is sharp. Through most of June, the PCR ran between 0.62 and 0.73, consistent with genuine defensive hedging. Since late June, puts have essentially been abandoned. The borrow market tells the same relaxed story — availability is extremely loose at 1,545%, meaning roughly fifteen shares remain available to borrow for every one currently lent out, and cost to borrow is a modest 0.53%.
Short interest adds little drama. Bears hold just 2.4% of the free float — a low reading that has barely moved over the week, down about 2%. The ORTEX short score of 38.4 ranks in the 35th percentile, consistent with a stock where short positioning is neither building nor a notable risk factor. The lending pool is deep, borrow is cheap, and there is no structural squeeze pressure. Shorts are simply not the story here.
The Street is cautiously constructive but not enthusiastic. Keefe, Bruyette & Woods lifted its price target to $33 this week — the third upward revision in seven months from the same analyst — while holding a Market Perform rating. At $28.42, the stock now trades at a 14% discount to that target. The PE multiple has compressed slightly over the past month to 11.8x, while EV/EBITDA has pulled back to 14.3x. The EPS surprise factor score of 82 is the standout — Hippo has consistently beaten estimates, putting it near the top of its universe on that metric. Peers had a strong week: LMND surged 25% and ROOT gained 10%, suggesting a sector-wide tailwind that HIPO's modest 0.6% weekly gain has yet to fully match.
One note of caution sits in the insider data. The CEO, CFO, and a subsidiary CEO all sold shares in May and early June, with the CEO alone selling across three separate dates. Net insider activity over 90 days registers a positive figure on paper — about 39,000 net shares — but the transaction log shows no purchases; the positive net figure likely reflects equity vesting mechanics rather than open-market buying. The Lennar Foundation holds 7.96% as the largest single institutional holder, and BlackRock added roughly 120,000 shares in its most recent reported period, so institutional flows are not uniformly negative.
With earnings due July 30, what to watch is whether that abrupt collapse in put demand — from a PCR above 0.70 to near zero in under two weeks — reflects genuine confidence ahead of the print, or simply a thin options market where a handful of call trades can swing the ratio dramatically.
See the live data behind this article on ORTEX.
Open HIPO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
